Test Price
550 AED✅ Home Collection Available
Immunophenotyping by Flow Cytometry (CD117) Test in UAE | 550 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
Immunophenotyping by Flow Cytometry (CD117) is a precision diagnostic assay that quantifies CD117 (c-Kit) antigen expression on hematopoietic cells, aiding the diagnosis and classification of hematologic malignancies such as acute myeloid leukemia, systemic mastocytosis, and myeloproliferative disorders. This test delivers rapid, same-day reporting with high sensitivity and specificity.
| Feature | Our Test: Flow Cytometry (CD117) | Closest Alternative: IHC on Biopsy |
|---|---|---|
| Methodology | Multiparametric fluorescent flow cytometry (6‑color) with direct CD117 staining | Immunohistochemistry on bone marrow biopsy sections |
| Turnaround Time | Same day (if sample received by 9 AM) | 3–5 working days |
| Detection Sensitivity | 0.01% abnormal population (quantitative) | ~1–5% visual estimation (semi‑quantitative) |
| Clinical Utility | Diagnosis, subclassification, minimal residual disease | Architectural assessment, supplementary marker |
Physician Insight & Safety Protocols
“As a diagnostic radiologist with experience in hematologic imaging correlation, I recognize that accurate diagnosis of blood cancers depends heavily on precise immunophenotyping. The CD117 assay delivers granular data on c-Kit expression, but results must always be integrated with clinical history and morphological findings. Patients should never adjust therapy based solely on this test.”
— Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA Registration ID: 61713011
Advisory: Medication Continuity
Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Active bleeding disorder, severe thrombocytopenia (<20,000/μL) without platelet support, known allergy to heparin (used in green-top tube).
- Emergency Red Flags After Bone Marrow Collection: Severe bone pain, persistent bleeding, fever ≥38.5°C, rapid swelling or redness at the aspiration site. Seek immediate medical attention.
Patient FAQ & Clinical Guidance
1. What is the CD117 test used for?
The CD117 immunophenotyping test identifies cells expressing c-Kit to diagnose mastocytosis, acute myeloid leukemia (AML), and other myeloproliferative disorders. It quantifies CD117‑positive populations by flow cytometry, providing essential data for subclassification, prognosis, and minimal residual disease monitoring in hematologic malignancies.
2. How is the sample collected for this test?
The test requires a bone marrow aspirate or peripheral blood sample collected by a trained medical professional within a hospital setting. Our logistics ensure secure, temperature-controlled transport from the hospital to our laboratory, bypassing home collection due to the invasive nature of the primary specimen.
3. When will I receive my CD117 test results?
Same-day reporting is provided if the sample arrives at the lab by 9 AM, ensuring rapid clinical decision‑making. Final validated reports are accessible through our secure patient portal or delivered directly to your referring doctor.
UAE Regulatory & Data Privacy Adherence
Data Protection: This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Accreditation: All procedures are performed at DNA Labs UAE, DHA Licensed Facility No. 1143, adhering to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and international standards for immunophenotyping.
Clinical & Logistical Metadata
| Test Name | Immunophenotyping by Flow Cytometry (CD117) |
| Price (AED) | 550 |
| Turnaround Time | Same day (if sample received by 9 AM) |
| Sample Type / Matrix | Bone Marrow Aspirate or Peripheral Blood |
| Methodology Used | Multiparametric fluorescent flow cytometry (6‑color) with direct CD117 staining |
| ICD-10-CM Code | C92.00 (Acute myeloblastic leukemia, not having achieved remission), C96.21 (Aggressive systemic mastocytosis), Z15.09 (Genetic susceptibility to other malignant neoplasm) |
| LOINC Code | 59062-0 |
| DHA Facility License & Laboratory Address | License No. 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians